Skip to main content Help with accessibility Skip to main navigation

Direct oral anticoagulants (DOACs) (previously known as NOACs) for the treatment and prevention of Deep Vein Thrombosis (DVT) and/or Pulmonary Embolism (PE)

Last Updated: 24 October 2019

Body System: Cardiovascular system

Amber initiated

DOACs are recommended as an option for treating and/or preventing recurrent DVT and/or PE where an oral anticoagulant is indicated following specialist initiation.

GREEN for NHS Wirral CCG
Oral Anticoagulants (VKA and DOAC). Guidelines for prescribing, monitoring and management.